Mtumiaji:Lucas559/Ugonjwa wa Autoimmune
| Lucas559/Ugonjwa wa Autoimmune | |
|---|---|
| Mwainisho na taarifa za nje | |
 | |
| Kundi Maalumu | Rheumatology, immunology, gastroenterology, neurology, dermatology |
| Dalili | Depends on the condition. Commonly low grade fever, feeling tired[1] |
| Miaka ya kawaida inapoanza | Adulthood[1] |
| Dawa | Nonsteroidal anti-inflammatory drugs, immunosuppressants, intravenous immunoglobulin[1][2] |
| Idadi ya utokeaji wake | 24 million / 7% (USA)[1][3] |
Ugonjwa wa autoimmune ni hali inayotokana na mwitikio usio wa kawaida wa kinga kwa sehemu ya mwili inayofanya kazi. [1] Kuna angalau aina 80 za magonjwa ya autoimmune. [1] Karibu sehemu yoyote ya mwili inaweza kuhusika. [3] Dalili za kawaida ni pamoja na homa ya kiwango cha chini na kuhisi uchovu . [1] Mara nyingi dalili huja na kwenda. [1]
Sababu kwa ujumla haijulikani. [3] Baadhi ya magonjwa ya kingamwili kama vile lupus hutokea katika familia, na visa vingine vinaweza kusababishwa na maambukizo au sababu zingine za mazingira. [1] Baadhi ya magonjwa ya kawaida ambayo kwa ujumla huchukuliwa kuwa ya kingamwili ni pamoja na ugonjwa wa celiac, kisukari aina ya 1, ugonjwa wa Graves, ugonjwa wa bowel uchochezi, ugonjwa wa sclerosis, psoriasis, arthritis ya rheumatoid, na lupus erythematosus ya utaratibu . [1] [4] Utambuzi unaweza kuwa ngumu kuamua. [1]
Matibabu inategemea aina na ukali wa hali hiyo. [1] Dawa zisizo za steroidal za kuzuia uchochezi (NSAIDs) na immunosuppressants hutumiwa mara nyingi. [1] Immunoglobulini ya mishipa inaweza pia kutumika mara kwa mara. [2] Ingawa matibabu kawaida huboresha dalili, sio kawaida kutibu ugonjwa huo. [1]
Takriban watu milioni 24 (7%) nchini Marekani wanaathiriwa na ugonjwa wa autoimmune. [1] [3] Wanawake huathirika zaidi kuliko wanaume. [1] Mara nyingi huanza wakati wa watu wazima. [1] Magonjwa ya kwanza ya autoimmune yalielezewa mapema miaka ya 1900. [5]
Marejeleo
hariri- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 "Autoimmune diseases fact sheet". Office on Women's Health. U.S. Department of Health and Human Services. 16 Julai 2012. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 5 Oktoba 2016. Iliwekwa mnamo 5 Oktoba 2016.
{{cite web}}: CS1 maint: date auto-translated (link) - ↑ 2.0 2.1 Katz U, Shoenfeld Y, Zandman-Goddard G (2011). "Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases". Current Pharmaceutical Design. 17 (29): 3166–75. doi:10.2174/138161211798157540. PMID 21864262.
- ↑ 3.0 3.1 3.2 3.3 Borgelt, Laura Marie (2010). Women's Health Across the Lifespan: A Pharmacotherapeutic Approach (kwa Kiingereza). ASHP. uk. 579. ISBN 978-1-58528-194-7. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 2017-09-08.
- ↑ Hohlfeld R, Dornmair K, Meinl E, Wekerle H (Februari 2016). "The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets". The Lancet. Neurology. 15 (2): 198–209. doi:10.1016/S1474-4422(15)00334-8. PMID 26724103.
{{cite journal}}: CS1 maint: date auto-translated (link) - ↑ Ananthanarayan R, Paniker CK (2005). Ananthanarayan and Paniker's Textbook of Microbiology (kwa Kiingereza). Orient Blackswan. uk. 169. ISBN 9788125028086. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 2017-09-08.
[[Category:Magonjwa]]